PARAMETRIC PORTFOLIO ASSOCIATES LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 79 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$1,889,000
+5.9%
256,291
-7.6%
0.00%0.0%
Q4 2021$1,784,000
+4.6%
277,519
-5.3%
0.00%0.0%
Q3 2021$1,706,000
-4.2%
293,130
+70.0%
0.00%0.0%
Q2 2021$1,780,000
+92.0%
172,474
+95.7%
0.00%0.0%
Q1 2021$927,000
-24.2%
88,111
+11.6%
0.00%0.0%
Q4 2020$1,223,000
+83.9%
78,979
+73.4%
0.00%
Q3 2020$665,000
-75.7%
45,538
-68.5%
0.00%
-100.0%
Q2 2020$2,739,000
-9.9%
144,600
-8.7%
0.00%
-33.3%
Q1 2020$3,041,000
+56.4%
158,310
+56.1%
0.00%
+200.0%
Q4 2019$1,944,000
+700.0%
101,395
+301.4%
0.00%
Q3 2019$243,000
+89.8%
25,261
+18.0%
0.00%
Q2 2019$128,000
-27.7%
21,405
+9.3%
0.00%
Q2 2017$177,000
-50.7%
19,583
-30.0%
0.00%
-100.0%
Q1 2017$359,000
+88.9%
27,988
+38.6%
0.00%
Q4 2016$190,000
-2.1%
20,199
+1.4%
0.00%
Q3 2016$194,000
-36.8%
19,925
+76.4%
0.00%
-100.0%
Q2 2015$307,000
-26.7%
11,298
+0.8%
0.00%0.0%
Q4 2014$419,00011,2050.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Delphi Management Partners VIII, L.L.C. 2,263,006$13,170,0009.51%
Palo Alto Investors LP 5,383,052$31,329,0001.89%
Birchview Capital, LP 246,000$1,432,0000.97%
Rubric Capital Management LP 3,375,758$19,647,0000.55%
Lombard Odier Asset Management (Switzerland) SA 1,517,804$8,834,0000.55%
RICE HALL JAMES & ASSOCIATES, LLC 1,401,861$8,159,0000.30%
AlphaCentric Advisors LLC 136,000$792,0000.20%
Bridgefront Capital, LLC 20,946$122,0000.13%
Hennion & Walsh Asset Management, Inc. 407,474$2,371,0000.12%
Virtus ETF Advisers LLC 44,364$258,0000.11%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders